Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Inhibitors of hydroxymethylglutaryl coenzyme A reductase for treating hypercholesterolaemia.

× No keyword cloud information.

3 in total

Review 1. Topics in clinical pharmacology: lovastatin.

Authors: R Sabra
Journal: Am J Med Sci Date: 1988-12 Impact factor: 2.378

2. HMG-CoA reductase inhibitors for hypercholesterolemia.

Authors:
Journal: N Engl J Med Date: 1988-11-03 Impact factor: 91.245

Review 3. 3-Hydroxy-3-methylglutaryl--coenzyme A reductase inhibitors in the treatment of hypercholesterolemia.

Authors: J M Hoeg; H B Brewer
Journal: JAMA Date: 1987-12-25 Impact factor: 56.272

3 in total

12 in total

Review 1. HMG-CoA reductase inhibitor use in the aged. A review of clinical experience.

Authors: C J Lintott; R S Scott
Journal: Drugs Aging Date: 1992 Nov-Dec Impact factor: 3.923

Review 2. How well tolerated are lipid-lowering drugs?

Authors: B Tomlinson; P Chan; W Lan
Journal: Drugs Aging Date: 2001 Impact factor: 3.923

3. Do cholesterol-lowering agents affect brain activity? A comparison of simvastatin, pravastatin, and placebo in healthy volunteers.

Authors: R W Harrison; C H Ashton
Journal: Br J Clin Pharmacol Date: 1994-03 Impact factor: 4.335

Review 4. Statins, mood, sleep, and physical function: a systematic review.

Authors: Kristopher J Swiger; Raoul J Manalac; Michael J Blaha; Roger S Blumenthal; Seth S Martin
Journal: Eur J Clin Pharmacol Date: 2014-10-08 Impact factor: 2.953

5. Tissue-selective inhibition of sterol synthesis in mice by pravastatin sodium after a single or repeated oral administrations.

Authors: T Koga; T Kikuchi; A Miyazaki; H Koike
Journal: Lipids Date: 1995-08 Impact factor: 1.880

Review 6. Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management.

Authors: Marco Tuccori; Sabrina Montagnani; Stefania Mantarro; Alice Capogrosso-Sansone; Elisa Ruggiero; Alessandra Saporiti; Luca Antonioli; Matteo Fornai; Corrado Blandizzi
Journal: CNS Drugs Date: 2014-03 Impact factor: 5.749

7. Prediction of the therapeutic response to simvastatin by pretreatment lipid concentrations in 2082 subjects.

Authors: A R Miserez; F A Rossi; U Keller
Journal: Eur J Clin Pharmacol Date: 1994 Impact factor: 2.953

8. In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors.

Authors: A Saheki; T Terasaki; I Tamai; A Tsuji
Journal: Pharm Res Date: 1994-02 Impact factor: 4.200

9. Association of statin use with sleep disturbances: data mining of a spontaneous reporting database and a prescription database.

Authors: Mitsutaka Takada; Mai Fujimoto; Kohei Yamazaki; Masashi Takamoto; Kouichi Hosomi
Journal: Drug Saf Date: 2014-06 Impact factor: 5.606

10. The effects of simvastatin and pravastatin on objective and subjective measures of nocturnal sleep: a comparison of two structurally different HMG CoA reductase inhibitors in patients with primary moderate hypercholesterolaemia.

Authors: S A Eckernäs; B E Roos; P Kvidal; L O Eriksson; G A Block; R P Neafus; J R Haigh
Journal: Br J Clin Pharmacol Date: 1993-03 Impact factor: 4.335